Nohria V - Search Results

1

A novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical development.

Sachdeo R, Partiot A, Biton V, Rosenfeld WE, Nohria V, Tompson D, DeRossett S, Porter RJ. Sachdeo R, et al. Among authors: nohria v. Int J Clin Pharmacol Ther. 2014 Jun;52(6):509-18. doi: 10.5414/CP202081. Int J Clin Pharmacol Ther. 2014. PMID: 24755135 Clinical Trial.

2

Retigabine.

Porter RJ, Nohria V, Rundfeldt C. Porter RJ, et al. Among authors: nohria v. Neurotherapeutics. 2007 Jan;4(1):149-54. doi: 10.1016/j.nurt.2006.11.012. Neurotherapeutics. 2007. PMID: 17199031 Free PMC article. Review.

3

Safety and tolerability of different titration rates of retigabine (ezogabine) in patients with partial-onset seizures.

Biton V, Gil-Nagel A, Brodie MJ, Derossett SE, Nohria V. Biton V, et al. Among authors: nohria v. Epilepsy Res. 2013 Nov;107(1-2):138-45. doi: 10.1016/j.eplepsyres.2013.08.021. Epub 2013 Sep 4. Epilepsy Res. 2013. PMID: 24094693 Clinical Trial.

4

Adjunctive use of ezogabine/retigabine with either traditional sodium channel blocking antiepileptic drugs (AEDs) or AEDs with other mechanisms of action: Evaluation of efficacy and tolerability.

Brodie MJ, French JA, McDonald SA, Lee WJ, Adams B, Scott A, Nohria V, DeRossett S. Brodie MJ, et al. Among authors: nohria v. Epilepsy Res. 2014 Jul;108(5):989-94. doi: 10.1016/j.eplepsyres.2014.03.008. Epub 2014 Mar 26. Epilepsy Res. 2014. PMID: 24726452

5

Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy.

French JA, Abou-Khalil BW, Leroy RF, Yacubian EM, Shin P, Hall S, Mansbach H, Nohria V; RESTORE 1/Study 301 Investigators. French JA, et al. Among authors: nohria v. Neurology. 2011 May 3;76(18):1555-63. doi: 10.1212/WNL.0b013e3182194bd3. Epub 2011 Mar 30. Neurology. 2011. PMID: 21451152 Clinical Trial.

6

Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures.

Porter RJ, Partiot A, Sachdeo R, Nohria V, Alves WM; 205 Study Group. Porter RJ, et al. Among authors: nohria v. Neurology. 2007 Apr 10;68(15):1197-204. doi: 10.1212/01.wnl.0000259034.45049.00. Neurology. 2007. PMID: 17420403 Clinical Trial.

7

Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.

Brodie MJ, Lerche H, Gil-Nagel A, Elger C, Hall S, Shin P, Nohria V, Mansbach H; RESTORE 2 Study Group. Brodie MJ, et al. Among authors: nohria v. Neurology. 2010 Nov 16;75(20):1817-24. doi: 10.1212/WNL.0b013e3181fd6170. Epub 2010 Oct 13. Neurology. 2010. PMID: 20944074 Clinical Trial.

8

Clinical development of drugs for epilepsy: a review of approaches in the United States and Europe.

Porter RJ, Baulac M, Nohria V. Porter RJ, et al. Among authors: nohria v. Epilepsy Res. 2010 May;89(2-3):163-75. doi: 10.1016/j.eplepsyres.2010.02.005. Epub 2010 Mar 29. Epilepsy Res. 2010. PMID: 20347575 Review.

9

Ganaxolone.

Nohria V, Giller E. Nohria V, et al. Neurotherapeutics. 2007 Jan;4(1):102-5. doi: 10.1016/j.nurt.2006.11.003. Neurotherapeutics. 2007. PMID: 17199022 Free PMC article. Review.

10

A splice junction mutation in a new myopathic variant of phosphoglycerate kinase deficiency (PGK North Carolina).

Tsujino S, Tonin P, Shanske S, Nohria V, Boustany RM, Lewis D, Chen YT, DiMauro S. Tsujino S, et al. Among authors: nohria v. Ann Neurol. 1994 Mar;35(3):349-53. doi: 10.1002/ana.410350316. Ann Neurol. 1994. PMID: 8122886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results